Stanford, California
Professor, Cardiothoracic Surgery
Stanford University School of Medicine
Medical Director, Catheterization and Angiography Laboratories
Stanford University Medical Center
SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2013
Session Moderator
SESSION-23: PROGRESS IN TREATING DISEASES OF THE THORACIC AORTA, INCLUDING TYPE B AORTIC DISSECTIONS (TBADS)
Presenter
SESSION 27: NEW INFORMATION ON RENAL DENERVATION AND INTERVENTIONAL
CCSVI Treatment Helps Some MS Patients: What We Know And What We Do Not Know: Is A Randomized Trial In The Works
4:41 PM - 4:46 PM
Presenter
SESSION 32: NEW DEVELOPMENTS IN TREATING CRITICAL LOWER EXTREMITY ISCHEMIA (CLI) IN STENT RESTENOSIS (ISR), ATHERECTOMY AND MORE ON DESS
DEBATE: New Findings From The ZILVER PTX Trial: Are The Benefits Of This DES Durable: Do The Good Results (3 Years And Beyond) Justify The Costs
11:18 AM - 11:23 AM
Presenter
SESSION 35: MORE LOWER EXTREMITY AND RELATED HOT TOPICS
New Findings From The ZILVER PTX Trial After 3 Years Of Observation: Do DESs Work As Well In Diabetics, For In Stent Restenosis And TASC C And D Lesions As For Standard Patients And Lesions
4:21 PM - 4:26 PM
Presenter
SESSION 37: NEW DEVELOPMENTS IN VENOUS DISEASE: TREATMENT OF LARGE VEIN DISEASE AND HOT TOPICS ON IVC FILTERS
DEBATE: Left Renal Vein Stenting Is The Best Treatment For The Nutcracker Syndrome And Pelvic Congestion
7:33 AM - 7:38 AM
Friday, November 22, 2013
Presenter
SESSION 74: ISSUES RELATED TO TRAINING, CERTIFICATION, SPECIALIZATION, SIMULATION, RANDOMIZED CONTROLLED TRIALS (RCTS)
DEBATE: Nonsense, RCTs And Level I Evidence May Be Misleading And Not Lead To Best Medical Practice
1:42 PM - 1:47 PM
 
previous next